Rune Labs is a software and data analytics company focused on precision neurology. Rune Labs develops tools to support care delivery and therapy development for neurological conditions.

Rune Labs

MetaBrain is a large scale eQTL meta-analysis of previously published human brain eQTL datasets, providing a browser for cis-eQTL and trans-eQTL meta-analysis in Cortex samples from European ancestry, as well as a gene network for annotating genes and performing gene set enrichment analyses.

MetaBrain

The last decade has seen amazing progress in neuroscience, enabling researchers to envision a new generation of brain machine interfaces. These systems will be used to treat chronic diseases like Parkinson's, epilepsy, and Alzheimer's. They will restore mobility to the paralyzed and speed recovery from a stroke. They may even allow us to control our mood and enhance our cognition. Rune Labs wants to build the software at the heart of these systems, and help accelerate the next wave of neuromodulation applications.

City Light Capital

Village Global

TruVenturo

DigiTx Partners

Loup Ventures

Moment Ventures

Eclipse Ventures

Nexus NeuroTech

Dr. Suketu Khandhar, Medical Director for Movement Disorders at Kaiser Permanente, shares why he uses our StrivePD precision medicine platform with his Parkinson's patients:

"Platforms like StrivePD act as a conduit of communication between clinicians and patients because they signal to both whether a treatment is working...we can allow the patient to be their navigator, empowering individuals to be involved in their Parkinson’s journey."

Looking forward to presenting early cost-savings data from our work with Kaiser at #mds2024 in Philadelphia later this year, while continuing to serve more and more Parkinson's patients with Kaiser Permanente around the US 🧠

On this World Parkinson's Day, we at Rune Labs renew our commitment to elevating the standard of care for every individual affected by Parkinson's. Our journey is defined by the voices of those living with Parkinson's and the caregivers and care teams who tirelessly support them.

To the remarkable individuals who bravely share their experiences and data with us, we are deeply inspired by your courage and strength. Your collaboration fuels our mission, and we are privileged to earn your trust. Your insights drive our innovation, shaping tools such as StrivePD that empower you to navigate your journey with greater ease.

To the clinicians, researchers, and industry partners who lend us their expertise and dedication, we extend our heartfelt appreciation. Your partnership is invaluable, guiding us as we strive to make meaningful advancements in Parkinson's care. Together, we forge a path towards a future where the impact of Parkinson's is minimized through groundbreaking treatments and technologies.

With your help, we are advancing towards a future where Parkinson's disease is met with more effective treatments. We extend our heartfelt thanks to everyone who has shared their journey with us. Your contributions are invaluable, driving us closer to fulfilling the unique needs of the Parkinson's community.

Brian Pepin

#parkinsons #parkinsonsawareness #StrivePD #pwpd #worldparkinsonsday

Rune Labs is excited to celebrate the signing of the National Plan to End Parkinson’s Disease into law. This groundbreaking legislation unites federal and philanthropic efforts to enhance diagnosis and treatment, ensuring essential care for American families.

Our CEO, Brian Pepin, highlights this milestone: "The National Plan to End Parkinson's Disease aligns perfectly with our mission at Rune Labs. We look forward to leveraging our StrivePD platform in partnership with the National Parkinson’s Project to make a real difference for the Parkinson’s community."

With our StrivePD platform, we’re revolutionizing Parkinson’s care through continuous, real-time symptom tracking via the Apple Watch, combined with AI-derived insights to optimize treatment.

Parkinson’s advocate, Benjamin Stecher, adds, "This plan brings new hope for the Parkinson's community. Together, through collaboration and innovation, we can significantly improve care."

We’re eager to collaborate with the Department of Health and Human Services and other stakeholders to achieve the goals of this national plan.

https://lnkd.in/ex56tZAe

#ParkinsonsDisease #PrecisionMedicine #HealthcareInnovation #StrivePD #RuneLabs #EndParkinsons #PrecisionNeurology

Rune Labs CEO and Founder, Brian Pepin, sat down with Fox KTVU 2 to discuss the recent signing of the National Plan to End Parkinson’s Act. This significant legislation will fund advancements in the early diagnosis of Parkinson’s disease and improve the coordination of care and treatment for those affected.

With StrivePD, people with Parkinson's can better understand their patterns and behaviors, enabling them to manage their disease more effectively and receive personalized care plans from their clinicians. StrivePD not only supports short- and long-term outcomes but also provides access to clinical trials for disease-modifying therapies.

At Rune Labs, we are excited to advance the National Plan to End Parkinson’s goals with StrivePD.

Watch the interview here: https://lnkd.in/eqyQhnC3

#StrivePD #EndParkinsons #parkinsons

Rune Labs CEO and Founder, Brian Pepin, and Lead Neuroscientist, Ro'ee Gilron, are attending the inaugural GBA1 meeting in Québec this week! 

Interested in learning more about Rune Labs? Schedule a meeting with us at info@runelabs.io. We would love to connect with you! 

https://lnkd.in/eGWV6cbs

#parkinsonsdisease #StrivePD #precisionneurology #MJFF #GBA1 #parkinsons

It was great connecting with you all at the AMDAPP (Association of Movement Disorder Advanced Practice Providers) annual meeting and the 3rd Annual Advanced Therapeutics in Movement & Related Disorders Congress (#ATMRD24) this past weekend. If we didn’t get the chance to connect in DC, please reach out to us at info@runelabs.io. 

Pictured here is Rune Labs Medical Liaison, Amanda Hare, DNP, and Community Manager, Jesse P. at our StrivePD booth. 

#AMDAPP #ATMRD #StrivePD #parkinsonsdisease #healthtechnology #precisionneurology

Metric
Company Name	Rune Labs	MetaBrain
Symbol
MSH ID	IO:RUNELABS	NL:METABRAIN
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare Technology	Genomics
Country	US	NL
Stage
Employee Count	55
Website	runelabs.io	metabrain.nl
LinkedIn	rune-labs	metabrainlabs
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital		11.48M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

IO:RUNELABS

Rune Labs

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue